文献速递神经眼科眼底病与葡萄膜炎

旁中心急性中层黄斑病变对动脉炎性前部缺血性视神经病变的诊断准确性

Diagnostic Accuracy of Paracentral Acute Middle Maculopathy for Arteritic Anterior Ischemic Optic Neuropathy.
PubMed 文献 · Am J Ophthalmol · 2026-10-29

本研究为美国多中心回顾性诊断准确性分析,纳入119例AAION或NAION患者,评估OCT黄斑区PAMM鉴别两者的价值。PAMM对AAION的敏感度为19%、特异度为94.6%,阳性预测值50%、阴性预测值79.8%。PAMM是高度特异但不敏感的AAION标志物,其出现应提高临床怀疑但需结合整体临床背景解读。

要点

  • PAMM对AAION高度特异(94.6%)但敏感度低(19%)。
  • PAMM阳性应提高AAION怀疑,但NAION也可出现,尤其全身低灌注时。
  • OCT黄斑PAMM需结合整体临床背景解读,不能单独确诊AAION。

核心结论

  • PAMM是高度特异但不敏感的OCT标志物,用于区分AAION与NAION。
  • PAMM阳性应增加对AAION的临床怀疑,但NAION中也可罕见出现,尤其伴全身低灌注时。
  • PAMM结果需结合整体临床背景进行解读。

研究设计与样本

  • 回顾性、多中心诊断准确性分析。
  • 纳入2020年1月至2025年1月在明尼苏达大学、梅奥诊所和约翰霍普金斯Wilmer眼科研究所诊断为AAION或NAION的患者。
  • 纳入标准为年龄大于50岁且在症状出现14天内完成OCT黄斑检查。
  • AAION诊断经颞动脉活检或正电子发射断层扫描/计算机断层扫描确认。
  • 由两名设盲的神经眼科专科医生独立评估OCT图像中急性PAMM的存在。

主要发现

  • 共纳入119例患者,其中AAION 27例,NAION 92例。
  • AAION患者中PAMM检出率为18.5%,NAION患者中为5.4%(p = 0.032)。
  • PAMM对AAION的敏感度为19% [95% CI: 0.08-0.37]。
  • PAMM对AAION的特异度为94.6% [95% CI: 0.88-0.98]。
  • PAMM对AAION的阳性预测值为50% [95% CI: 0.24-0.76],阴性预测值为79.8% [95% CI: 0.71-0.86]。

关键数值与推荐

  • PAMM对AAION的敏感度为19% [95% CI: 0.08-0.37]。
  • PAMM对AAION的特异度为94.6% [95% CI: 0.88-0.98]。
  • PAMM对AAION的阳性预测值为50% [95% CI: 0.24-0.76]。
  • PAMM对AAION的阴性预测值为79.8% [95% CI: 0.71-0.86]。
  • 5例NAION伴PAMM患者中3例为与严重全身低灌注相关的诱发型NAION。

临床怎么用

  • OCT黄斑发现PAMM时应提高对AAION的怀疑,但因其敏感度低,PAMM阴性不能排除AAION。
  • PAMM阳性也可见于NAION,尤其伴全身低灌注时,需结合整体临床背景综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to evaluate the diagnostic accuracy of paracentral acute middle maculopathy (PAMM) detected on optical coherence tomography (OCT) macula for differentiating arteritic anterior ischemic neuropathy (AAION) from nonarteritic anterior ischemic optic neuropathy (NAION) in a multicenter United States cohort. DESIGN: Retrospective, multicenter diagnostic accuracy analysis. PARTICIPANTS: This study included patients diagnosed with AAION or NAION at the University of Minnesota, Mayo Clinic, and Johns Hopkins Wilmer Eye Institute between January 2020 and January 2025. Inclusion criteria consisted of patients older than 50 years who had obtained OCT macula within 14 days of symptom onset. AAION diagnoses were confirmed by temporal artery biopsy or positron emission tomography/computed tomography. METHODS: Two masked fellowship-trained neuro-ophthalmologists independently evaluated OCT images for the presence of acute PAMM. MAIN OUTCOME MEASURES: Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of PAMM for AAION were calculated. RESULTS: A total of 119 patients were included, consisting of 27 patients with AAION and 92 patients with NAION. PAMM was identified in 18.5% of patients with AAION and 5.4% of patients with NAION (p = 0.032). The sensitivity, specificity, PPV, and NPV of PAMM for AAION was 19% [95% CI: 0.08-0.37], 94.6% [95% CI: 0.88-0.98], 50% [95% CI: 0.24-0.76], and79.8% [95% CI: 0.71-0.86] respectively. Three of five NAION patients with PAMM had provoked NAION associated with severe systemic hypoperfusion. CONCLUSION: PAMM is a highly specific but insensitive OCT marker for AAION. Although its presence should increase clinical suspicion for AAION, PAMM may rarely occur in patients with NAION particularly in the setting of systemic hypoperfusion and should be interpreted within the overall clinical context.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Molleti, Lang, Owosela, et al. Diagnostic Accuracy of Paracentral Acute Middle Maculopathy for Arteritic Anterior Ischemic Optic Neuropathy. Am J Ophthalmol. 2026. PMID: 42957016. doi:10.1016/j.ajo.2026.10.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。